BERYL DRUGS LTD. - Board Meeting Intimation for To Take Note Of General Disclosures Of Interest Of Directors Under Section 184 (1) In Form MBP-1 For The Year Ended 2024-2025

Download	< Back
12 Apr 2024
BERYL DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/04/2024 ,inter alia, to consider and approve 1. To take note of general disclosures of interest of Directors under section 184 (1) in form MBP-1 for the year ended 2024-2025 2. To consider and approve the appointment of Abhay Bhandari & Associates, Chartered Accountants as Internal Auditor of the Company for the Financial Year 2024-2025. 3. To consider and approve the appointment of Dipika Kataria, Practicing Company Secretary as Secretarial Auditor of the Company for the year 2024-2025 4. Authority to Mr. Sudhir Sethi as signing authority to apply and sign all the tender related documents on behalf of the Company for the year 2024-2025
View all announcements for BERYL DRUGS LTD.	Source: BSE India

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Management Speaks Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2024	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Market Astrology Advertise with us